Tau Subtypes of Alzheimer's Disease Determined in vivo Using Flortaucipir PET Imaging

被引:24
|
作者
Charil, Arnaud [1 ]
Shcherbinin, Sergey [1 ]
Southekal, Sudeepti [5 ]
Devous, Michael D. [5 ]
Mintun, Mark [1 ,5 ]
Murray, Melissa E. [4 ]
Miller, Bradley B. [1 ]
Schwarz, Adam J. [1 ,2 ,3 ]
机构
[1] Eli Lilly & Co, Indianapolis, IN 46285 USA
[2] Indiana Univ, Dept Psychol & Brain Sci, Bloomington, IN USA
[3] Indiana Univ, Dept Radiol & Imaging Sci, Indianapolis, IN 46204 USA
[4] Mayo Clin, Jacksonville, FL 32224 USA
[5] Avid Radiopharmaceut, Philadelphia, PA USA
关键词
Hippocampal sparing; limbic predominant; subtype; tau; NEUROPATHOLOGICALLY DEFINED SUBTYPES; MILD COGNITIVE IMPAIRMENT; ASSOCIATION WORKGROUPS; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; ATROPHY; F-18-AV-1451; PATHOLOGY; RECOMMENDATIONS; PATTERNS;
D O I
10.3233/JAD-190264
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
At autopsy, individuals with Alzheimer's disease (AD) exhibit heterogeneity in the distribution of neurofibrillary tangles in neocortical and hippocampal regions. Subtypes of AD, defined using an algorithm based on the relative number of tangle counts in these regions, have been proposed-hippocampal sparing (relative sparing of the hippocampus but high cortical load), limbic predominant (high hippocampal load but lower load in association cortices), and typical (balanced neurofibrillary tangles counts in the hippocampus and association cortices) AD-and shown to be associated with distinct antemortem clinical phenotypes. The ability to distinguish these AD subtypes from the more typical tau signature in vivo could have important implications for clinical research. Flortaucipir positron emission tomography (PET) images acquired from 45 amyloid-positive participants, defined clinically as mild cognitive impairment or AD, aged 50-92 years, 56% female, and estimated to be Braak V-VI based on their PET pattern of tau pathology, were studied. By translating the neuropathologic algorithm to flortaucipir PET scans, patterns of tau pathology consistent with autopsy findings, and with a similar prevalence, were identified in vivo. 6/45 (13%) participants were identified as hippocampal sparing and 6/45 (13%) as limbic predominant AD subtypes. Hippocampal sparing participants were significantly younger than those assigned to the other two subtypes. Worse performance on delayed recall was associated with increased hippocampal tau signal, and worse performance on the trail making test B-A was associated with lower values of the hippocampus to cortex ratio. Prospective studies can further validate the flortaucipir SUVR cut-points and the phenotype of the corresponding AD subtypes.
引用
收藏
页码:1037 / 1048
页数:12
相关论文
共 50 条
  • [31] Test-retest repeatability of [18F]Flortaucipir PET in Alzheimer's disease and cognitively normal individuals
    Timmers, Tessa
    Ossenkoppele, Rik
    Visser, Denise
    Tuncel, Hayel
    Wolters, Emma E.
    Verfaillie, Sander C. J.
    van der Flier, Wiesje M.
    Boellaard, Ronald
    Golla, Sandeep S., V
    van Berckel, Bart N. M.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (12) : 2464 - 2474
  • [32] Entorhinal Tau Predicts Hippocampal Activation and Memory Deficits in Alzheimer's Disease
    Richter, Nils
    Bischof, Gerard N.
    Dronse, Julian
    Nellessen, Nils
    Neumaier, Bernd
    Langen, Karl-Josef
    Drzezga, Alexander
    Fink, Gereon R.
    van Eimeren, Thilo
    Kukolja, Juraj
    Onur, Oezguer A.
    JOURNAL OF ALZHEIMERS DISEASE, 2020, 78 (04) : 1601 - 1614
  • [33] Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology
    Smith, Ruben
    Wibom, Moa
    Pawlik, Daria
    Englund, Elisabet
    Hansson, Oskar
    JAMA NEUROLOGY, 2019, 76 (03) : 310 - 317
  • [34] A human brain tau PET template in MNI space for the voxel-wise analysis of Alzheimer's disease
    Sun, Xi
    Liang, Shengxiang
    Fu, Liping
    Zhang, Xiaojun
    Feng, Ting
    Li, Panlong
    Zhang, Tianhao
    Wang, Luying
    Yin, Xiaolong
    Zhang, Wei
    Hu, Yichao
    Liu, Hua
    Zhao, Shujun
    Nie, Binbin
    Xu, Baixuan
    Shan, Baoci
    JOURNAL OF NEUROSCIENCE METHODS, 2019, 328
  • [35] Tau Positron Emission Tomographic Imaging in Aging and Early Alzheimer Disease
    Johnson, Keith A.
    Schultz, Aaron
    Betensky, Rebecca A.
    Becker, J. Alex
    Sepulcre, Jorge
    Rentz, Dorene
    Mormino, Elizabeth
    Chhatwal, Jasmeer
    Amariglio, Rebecca
    Papp, Kate
    Marshall, Gad
    Albers, Mark
    Mauro, Samantha
    Pepin, Lesley
    Alverio, Jonathan
    Judge, Kelly
    Philiossaint, Marlie
    Shoup, Timothy
    Yokell, Daniel
    Dickerson, Bradford
    Gomez-Isla, Teresa
    Hyman, Bradley
    Vasdev, Neil
    Sperling, Reisa
    ANNALS OF NEUROLOGY, 2016, 79 (01) : 110 - 119
  • [36] In vivo measurement of widespread synaptic loss in Alzheimer's disease with SV2A PET
    Mecca, Adam P.
    Chen, Ming-Kai
    O'Dell, Ryan S.
    Naganawa, Mika
    Toyonaga, Takuya
    Godek, Tyler A.
    Harris, Joanna E.
    Bartlett, Hugh H.
    Zhao, Wenzhen
    Nabulsi, Nabeel B.
    Vander Wyk, Brent C.
    Varma, Pradeep
    Arnsten, Amy F. T.
    Huang, Yiyun
    Carson, Richard E.
    van Dyck, Christopher H.
    ALZHEIMERS & DEMENTIA, 2020, 16 (07) : 974 - 982
  • [37] 18F-Flortaucipir PET/MRI Correlations in Nonamnestic and Amnestic Variants of Alzheimer Disease
    Nasrallah, Ilya M.
    Chen, Yin Jie
    Hsieh, Meng-Kang
    Phillips, Jeffrey S.
    Ternes, Kylie
    Stockbower, Grace E.
    Sheline, Yvette
    McMillan, Corey T.
    Grossman, Murray
    Wolk, David A.
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (02) : 299 - 306
  • [38] Longitudinal tau PET in ageing and Alzheimer's disease
    Jack, Clifford R., Jr.
    Wiste, Heather J.
    Schwarz, Christopher G.
    Lowe, Val J.
    Senjem, Matthew L.
    Vemuri, Prashanthi
    Weigand, Stephen D.
    Therneau, Terry M.
    Knopman, Dave S.
    Gunter, Jeffrey L.
    Jones, David T.
    Graff-Radford, Jonathan
    Kantarci, Kejal
    Roberts, Rosebud O.
    Mielke, Michelle M.
    Machulda, Mary M.
    Petersen, Ronald C.
    BRAIN, 2018, 141 : 1517 - 1528
  • [39] Tau PET Imaging for Staging of Alzheimer's Disease in Down Syndrome
    Rafii, Michael S.
    DEVELOPMENTAL NEUROBIOLOGY, 2019, 79 (07) : 711 - 715
  • [40] Tau Imaging in Alzheimer's Disease Diagnosis and Clinical Trials
    Brosch, Jared R.
    Farlow, Martin R.
    Risacher, Shannon L.
    Apostolova, Liana G.
    NEUROTHERAPEUTICS, 2017, 14 (01) : 62 - 68